Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication

This publication has 7 references indexed in Scilit:

• Remote Data Pacemaker
  Published by American Medical Association (AMA) ,2001
• Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors
  Antiviral Research, 2001
• Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults
  Antimicrobial Agents and Chemotherapy, 2001
• Management of hepatitis B: 2000—Summary of a workshop
  Gastroenterology, 2001
• Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region
  Hepatology, 2001
• Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
  Hepatology, 2000
• Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L‐FMAU, DAPD, penciclovir and lobucavir
  Journal of Viral Hepatitis, 2000